[HTML][HTML] Mechanism, safety and efficacy of three tyrosine kinase inhibitors lapatinib, neratinib and pyrotinib in HER2-positive breast cancer

JC Xuhong, XW Qi, Y Zhang, J Jiang - American journal of cancer …, 2019 - ncbi.nlm.nih.gov
The incidence of breast cancer ranks first among female malignant tumors that affect
women's health. Epidermal growth factor receptor (EGFR) family overexpression, especially …

Intestinal secretory mechanisms and diarrhea

SJ Keely, KE Barrett - American Journal of Physiology …, 2022 - journals.physiology.org
One of the primary functions of the intestinal epithelium is to transport fluid and electrolytes
to and from the luminal contents. Under normal circumstances, absorptive and secretory …

Mg2+ supplementation treats secretory diarrhea in mice by activating calcium-sensing receptor in intestinal epithelial cells

L de Souza Goncalves, T Chu, R Master… - The Journal of …, 2024 - Am Soc Clin Investig
Cholera is a global health problem with no targeted therapies. The Ca2+-sensing receptor
(CaSR) is a regulator of intestinal ion transport and a therapeutic target for diarrhea, and …

Diarrhea induced by small molecule tyrosine kinase inhibitors compared with chemotherapy: potential role of the microbiome

KR Secombe, YZA Van Sebille… - Integrative Cancer …, 2020 - journals.sagepub.com
Small molecule receptor tyrosine kinase inhibitors (SM-TKIs) are among a group of targeted
cancer therapies, intended to be more specific to cancer cells compared with treatments …

FDA-approved drug screening in patient-derived organoids demonstrates potential of drug repurposing for rare cystic fibrosis genotypes

E De Poel, S Spelier, MC Hagemeijer… - Journal of Cystic …, 2023 - Elsevier
Background Preclinical cell-based assays that recapitulate human disease play an
important role in drug repurposing. We previously developed a functional forskolin induced …

Population pharmacokinetics, pharmacogenomics, and adverse events of osimertinib and its two active metabolites, AZ5104 and AZ7550, in Japanese patients with …

E Ishikawa, Y Yokoyama, H Chishima, H Kasai… - Investigational new …, 2023 - Springer
Background: Potential novel strategies for adverse event (AE) management of osimertinib
therapy, including therapeutic drug monitoring and the use of biomarkers, have not yet been …

Chloride transport modulators as drug candidates

AS Verkman, LJV Galietta - American Journal of Physiology …, 2021 - journals.physiology.org
Chloride transport across cell membranes is broadly involved in epithelial fluid transport, cell
volume and pH regulation, muscle contraction, membrane excitability, and organellar …

Management of diarrhea induced by EGFR-TKIs in advanced lung adenocarcinoma

D Cárdenas-Fernández… - Therapeutic …, 2023 - journals.sagepub.com
The identification of Epidermal Growth Factor Receptor (EGFR) mutations in lung
adenocarcinoma has facilitated the development of personalized medicine based on …

Loureirin C extracted from Dracaena cochinchinensis SC Chen prevents rotaviral diarrhea in mice by inhibiting the intestinal Ca2+-activated Cl− channels

SC Guo, B Yu, Q Jia, HY Yan, LQ Wang, FF Sun… - Journal of …, 2024 - Elsevier
Abstract Ethnopharmacological relevance Resina Draconis (RD) is the red resin of
Dracaena cochinchinensis (Lour.) SC Chen and most used as a hemostatic drug in …

Potentiation of calcium‐activated chloride secretion and barrier dysfunction may underlie EGF receptor tyrosine kinase inhibitor‐induced diarrhea

Y Kim, A Quach, S Das, KE Barrett - Physiological reports, 2020 - Wiley Online Library
Epidermal growth factor receptor tyrosine kinase inhibitors (EGFr TKIs) are first‐line
therapies for various cancers, and cause dose‐limiting severe diarrhea in many patients. We …